Joint efforts will advance hybrid/electric vehicle-related semiconductor technology and emphasize transition from research to production Geneva, Switzerland, February 4, […]
argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic products […]